Applied metabolomics in drug discovery

References

• Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29:1181–1189. doi:10.1080/004982599238047.
   PubMed Web of Science ®Google Scholar
• Lommen A, van der Weg G, van Engelen MC, et al. An untargeted metabolomics approach to contaminant analysis: pinpointing potential unknown compounds. Anal Chim Acta. 2007;584:43–49. doi:10.1016/j.aca.2006.11.018.
   PubMed Web of Science ®Google Scholar
• Sanford K, Soucaille P, Whited G, et al. Genomics to fluxomics and physiomics — pathway engineering. Curr Opin Microbiol. 2002;5:318–322.
   PubMed Web of Science ®Google Scholar
• Han X, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res. 2003;44:1071–1079. doi:10.1194/jlr.R300004-JLR200.
   PubMed Web of Science ®Google Scholar
• Holmes E, Loo RL, Cloarec O, et al. Detection of urinary drug metabolite (Xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy. Anal Chem. 2007;79:2629–2640. doi:10.1021/ac062305n.
   PubMed Web of Science ®Google Scholar
• Lammerhofer M, Weckwerth W, editors. Metabolomics in practice: successful strategies to generate and analyze metabolic data. Weinheim: Wiley-VCH Verlag; 2013.
   Google Scholar
• Fan TW, Lane AN, Higashi RM, editors. The handbook of metabolomics. New York : Springer Science/Business Media; 2012.
   Google Scholar
• Prosser G, Larrouy-Maumus G, De Carvalho LPS. Metabolomic strategies for the identification of new enzyme functions and metabolic pathways. EMBO Rep. 2014;15(6):657–669.
   PubMed Web of Science ®Google Scholar
• Haycock JW. 3D cell culture: a review of current approaches and techniques. Methods Mol Biol. 2011;695:1–15. doi:10.1007/978-1-60761-984-0_1.
   PubMedGoogle Scholar
• Fatehullah A, Tan SH, Barker N. Organoids as an in vitro model of human development and disease. Nat Cell Biol. 2016;18(3):246–254. doi:10.1038/ncb3312.
   PubMed Web of Science ®Google Scholar
• Jeong ES, Kim G, Shin HJ, et al. Increased serum bile acid concentration following low-dose chronic administration of thioacetamide in rats, as evidenced by metabolomic analysis. Toxicol Appl Pharmacol. 2015;288(2):213–222. doi:10.1016/j.taap.2015.07.016.
   PubMed Web of Science ®Google Scholar
• Mattes W, Davis K, Fabian E, et al. Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma. Toxicol Lett. 2014;230(3):467–478. doi:10.1016/j.toxlet.2014.07.021.
   PubMed Web of Science ®Google Scholar
• Weiler S, Merz M, Kullak-Ublick GA. Drug-induced liver injury: the dawn of biomarkers? F1000Prime Rep. 2015;7:34. doi:10.12703/p.
   PubMedGoogle Scholar
• Zaitsu K, Hayashi Y, Kusano M, et al. Application of metabolomics to toxicology of drugs of abuse: a mini review of metabolomics approach to acute and chronic toxicity studies. Drug Metab Pharmacokinet. 2016;31:21–26. doi:10.1016/j.dmpk.2015.10.002.
   PubMed Web of Science ®Google Scholar
• Forgue P, Halouska S, Werth M, et al. NMR metabolic profiling of Aspergillus nidulans to monitor drug and protein activity. J Proteome Res. 2006;5:1916–1923.
   PubMed Web of Science ®Google Scholar
• Lefort N, Brown A, Lloyd V, et al. ¹H NMR metabolomics analysis of the effect of dichloroacetate and allopurinol on breast cancers. J Pharm Biomed Anal. 2014;93:77–85. doi:10.1016/j.jpba.2013.08.017.
   PubMed Web of Science ®Google Scholar
• Yoshinari K, Yamashita K. Analytical chemistry for ADMET research: recent advances and future directions in LC–MS/MS and omics approaches. Drug Metab. Pharmacokinet. 2016;31:1–2.
   Google Scholar
• Miura M, Takahashi N. Routine therapeutic drug monitoring of tyrosine kinase inhibitors by HPLC-UV or LC-MS/MS methods. Drug Metab Pharmacokinet. 2016;31:12–20. doi:10.1016/j.dmpk.2015.09.002.
   PubMed Web of Science ®Google Scholar
• Majors PD, McLean JS, Scholten JCM. NMR bioreactor development for live in-situ microbial functional analysis. J Magn Reson. 2008;192(1):159–166. doi:10.1016/j.jmr.2008.02.014.
   PubMed Web of Science ®Google Scholar
• Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14(2):111–129. doi:10.1038/nrd4510.
   PubMed Web of Science ®Google Scholar
• Johnson SR, Lange BM. Open-access metabolomics databases for natural product research: present capabilities and future potential. Front Bioeng Biotechnol. 2015;3:1–10. doi:10.3389/fbioe.2015.00022.
   PubMedGoogle Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75:311–335. doi:10.1021/np200906s.
   PubMed Web of Science ®Google Scholar
• Yuliana ND, Khatib A, Choi YH, et al. Metabolomics for bioactivity assessment of natural products. Phytother Res. 2011;25(2):157–169.
   PubMed Web of Science ®Google Scholar
• Kurita KL, Glassey E, Linington RG. Integration of high-content screening and untargeted metabolomics for comprehensive functional annotation of natural product libraries. Proc Natl Acad Sci. 2015;112(39):11999–12004. doi:10.1073/pnas.1507743112.
   PubMed Web of Science ®Google Scholar
• Kim S, Thiessen PA, Bolton EE, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44(D1):D1202–D1213
   Web of Science ®Google Scholar
• Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009;37(Database):D603–D610. doi:10.1093/nar/gkn810.
   PubMedGoogle Scholar
• Markley JL, Anderson ME, Cui Q, et al. New bioinformatics resources for metabolomics. Pac Symp Biocomput. 2007;168:157–168.
   Google Scholar
• Jewison T, Knox C, Neveu V, et al. YMDB: the Yeast Metabolome Database. Nucleic Acids Res. 2012;40(D1):D815–D820. doi:10.1093/nar/gkr916.
   Google Scholar
• Kopka J, Schauer N, Krueger S, et al. [email protected]: the Golm metabolome database. Bioinformatics. 2005;21(8):1635–1638. doi:10.1093/bioinformatics/bti236.
   PubMed Web of Science ®Google Scholar
• Tulpan D, Léger S, Belliveau L, et al. MetaboHunter: an automatic approach for identification of metabolites from 1H-NMR spectra of complex mixtures. BMC Bioinformatics. 2011;12:400. doi:10.1186/1471-2105-12-400.
   PubMed Web of Science ®Google Scholar
• Jeffryes JG, Colastani RL, Elbadawi-Sidhu M, et al. MINEs: open access databases of computationally predicted enzyme promiscuity products for untargeted metabolomics. J Cheminform. 2015;7(1):44.
   PubMed Web of Science ®Google Scholar
• Hoffmann T, Krug D, Hüttel S, et al. Improving natural products identification through targeted LC-MS/MS in an untargeted secondary metabolomics workflow. Anal Chem. 2014;86(21):10780–10788. doi:10.1021/ac502805w.
   PubMed Web of Science ®Google Scholar
• Böröczky K, Laatsch H, Wagner-Döbler I, et al. Cluster analysis as selection and dereplication tool for the identification of new natural compounds from large sample sets. Chem Biodivers. 2006;3(6):622–634. doi:10.1002/cbdv.200690065.
   PubMed Web of Science ®Google Scholar
• Halabalaki M, Vougogiannopoulou K, Mikros E, et al. Recent advances and new strategies in the NMR-based identification of natural products. Curr Opin Biotechnol. 2014;25:1–7. doi:10.1016/j.copbio.2013.08.005.
   PubMed Web of Science ®Google Scholar
• Hufsky F, Scheubert K, Böcker S. New kids on the block: novel informatics methods for natural product discovery. Nat Prod Rep. 2014;31(6):807–817. doi:10.1039/c3np70101h.
   PubMed Web of Science ®Google Scholar
• Kleigrewe K, Almaliti J, Tian IY, et al. Mass spectrometric metabolic profiling with genomic analysis: a powerful approach for discovering natural products from cyanobacteria. J Nat Prod. 2015;78:1671–1682.
   PubMed Web of Science ®Google Scholar
• Bingol K, Brüschweiler R. Multidimensional approaches to NMR-based metabolomics. Anal Chem. 2014;86(1):47–57. doi:10.1021/ac403520j.
   PubMed Web of Science ®Google Scholar
• Bingol K, Bruschweiler-Li L, Li D-W, et al. Customized metabolomics database for the analysis of NMR 1H-1H TOCSY and 13C-1H HSQC-TOCSY spectra of complex mixtures. Anal Chem. 2014;86(11):5494–5501. doi:10.1021/ac500979g.
   PubMed Web of Science ®Google Scholar
• Bingol K, Bruschweiler-Li L, Yu C, et al. Metabolomics beyond spectroscopic databases: a combined MS/NMR strategy for the rapid identification of new metabolites in complex mixtures. Anal Chem. 2015;87(7):3864–3870. doi:10.1021/ac504633z.
   PubMed Web of Science ®Google Scholar
• Johnson CS Jr. Diffusion ordered nuclear magnetic resonance spectroscopy: principles and applications. Prog Nucl Magn Reson Spectrosc. 1999;34:203–256. doi:10.1016/S0079-6565(99)00003-5.
   Web of Science ®Google Scholar
• Novoa-Carballal R, Fernandez-Megia E, Jimenez C, et al. NMR methods for unravelling the spectra of complex mixtures. Nat Prod Rep. 2011;28(1):78–98. doi:10.1039/C005320C.
   PubMed Web of Science ®Google Scholar
• Simmler C, Napolitano JG, McAlpine JB, et al. Quantitative NMR analysis of complex natural samples. Curr Opin Biotechnol. 2014;25:51–59. doi:10.1016/j.copbio.2013.08.004.
   PubMed Web of Science ®Google Scholar
• Fonville JM, Maher AD, Coen M, et al. Evaluation of full-resolution J-resolved 1H NMR projections of biofluids for metabonomics information retrieval and biomarker identification. Anal Chem. 2010;82(5):1811–1821. doi:10.1021/ac902443k.
   PubMed Web of Science ®Google Scholar
• Beltran A, Suarez M, Rodríguez M, et al. Assessment of compatibility between extraction methods for NMR- and LC/MS-based metabolomics. Anal Chem. 2012;84(14):5838–5844. doi:10.1021/ac3005567.
   PubMed Web of Science ®Google Scholar
• Zhang F, Brüschweiler R. Robust deconvolution of complex mixtures by covariance TOCSY spectroscopy. Angew Chem. 2007;119(15):2693–2696. doi:10.1002/ange.200604599.
   Google Scholar
• Zhang F, Bruschweiler-Li L, Robinette SL, et al. Self-consistent metabolic mixture analysis by heteronuclear NMR. Application to a human cancer cell line. Anal Chem. 2008;80(19):7549–7553. doi:10.1021/ac801116u.
   PubMed Web of Science ®Google Scholar
• Zhang F, Robinette SL, Bruschweiler-Li L, et al. Web server suite for complex mixture analysis by covariance NMR. Magn Reson Chem. 2009;47(S1):S118–S122. doi:10.1002/mrc.v47.1s.
   Google Scholar
• Clendinen CS, Pasquel C, Ajredini R, et al. 13 C NMR metabolomics: INADEQUATE network analysis. Anal Chem. 2015;87(11):5698–5706. doi:10.1021/acs.analchem.5b00867.
   PubMed Web of Science ®Google Scholar
• Simpson AJ, Woods G, Mehrzad O. Spectral editing of organic mixtures into pure components using NMR spectroscopy and ultraviscous solvents. Anal Chem. 2008;80(1):186–194. doi:10.1021/ac702119d.
   PubMed Web of Science ®Google Scholar
• Grkovic T, Pouwer RH, Vial M-L, et al. NMR fingerprints of the drug-like natural-product space identify iotrochotazine a: a chemical probe to study Parkinson’s disease. Angew Chem Int Ed. 2014;53(24):6070–6074. doi:10.1002/anie.201402239.
   PubMed Web of Science ®Google Scholar
• Grkovic T, Pouwer RH, Wang Q, et al. LAT transport inhibitors from Pittosporum venulosum identified by NMR fingerprint analysis. J Nat Prod. 2015;78(6):1215–1220. doi:10.1021/np500752y.
   PubMed Web of Science ®Google Scholar
• Jia J, Zhang F, Li Z, et al. Comparison of fruits of Forsythia suspensa at two different maturation stages by NMR-based metabolomics. Molecules. 2015;20(6):10065–10081. doi:10.3390/molecules200610065.
   PubMed Web of Science ®Google Scholar
• Kim H-Y, Lee S-G, Oh T-J, et al. Antiproliferative and apoptotic activity of chamaecyparis obtusa leaf extract against the HCT116 human colorectal cancer cell line and investigation of the bioactive compound by gas chromatography-mass spectrometry-based metabolomics. Molecules. 2015;20(10):18066–18082. doi:10.3390/molecules201018066.
   PubMed Web of Science ®Google Scholar
• Sientzoff P, Hubert J, Janin C, et al. Fast identification of radical scavengers from securigera varia by combining 13C-NMR-based dereplication to bioactivity-guided fractionation. Molecules. 2015;20(8):14970–14984. doi:10.3390/molecules200814970.
   PubMed Web of Science ®Google Scholar
• Roessner U, Anthone D, editors. Metabolomics tools for natural product discovery. New York : Springer Science/Business Media; 2013.
   Google Scholar
• Lipinski C, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012;64(SUPPL.):4–17. doi:10.1016/j.addr.2012.09.019.
   Web of Science ®Google Scholar
• Cumming JG, Davis AM, Muresan S, et al. Chemical predictive modelling to improve compound quality. Nat Rev Drug Discov. 2013;12(12):948–962. doi:10.1038/nrd4128.
   PubMed Web of Science ®Google Scholar
• Van De Waterbeemd H, Gifford E. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov. 2003;2(3):192–204. doi:10.1038/nrd1032.
   PubMed Web of Science ®Google Scholar
• Powers R. The current state of drug discovery and a potential role for NMR metabolomics. J Med Chem. 2014;57:5860–5870. doi:10.1021/jm401509e.
   PubMed Web of Science ®Google Scholar
• Lindon JC, Keun HC, Ebbels TM, et al. The consortium for metabonomic toxicology (COMET): aims, activities and achievements. Pharmacogenomics. 2005;6(7):691–699. doi:10.2217/14622416.6.7.691.
   PubMed Web of Science ®Google Scholar
• Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016 Mar 11. doi:10.1038/nrd.2016.32.
   PubMedGoogle Scholar
• Mueller SO, Dekant W, Jennings P, et al. Comprehensive summary - predict-IV: a systems toxicology approach to improve pharmaceutical drug safety testing. Toxicol In Vitro. 2015;30:4–6.
   Web of Science ®Google Scholar
• Wilmes A, Limonciel A, Aschauer L, et al. Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. J Proteomics. 2013;79:180–194. doi:10.1016/j.jprot.2012.11.022.
   PubMed Web of Science ®Google Scholar
• Macarron R, Banks MN, Bojanic D, et al. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov. 2011;10(3):188–195. doi:10.1038/nrd3368.
   PubMed Web of Science ®Google Scholar
• Wassermann AM, Lounkine E, Hoepfner D, et al. Dark chemical matter as a promising starting point for drug lead discovery. Nat Chem Biol. 2015;11(12):958–966. doi:10.1038/nchembio.1936.
   PubMed Web of Science ®Google Scholar
• Keiser MJ, Setola V, Irwin JJ, et al. Predicting new molecular targets for known drugs. Nature. 2009;462(7270):175–181. doi:10.1038/nature08506.
   PubMed Web of Science ®Google Scholar
• Tiziani S, Kang Y, Choi JS, et al. Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library. Nat Commun. 2011;2:545. doi:10.1038/ncomms1562.
   PubMed Web of Science ®Google Scholar
• Halouska S, Chacon O, Fenton RJ, et al. Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase. J Proteome Res. 2007;6(12):4608–4614. doi:10.1021/pr0704332.
   PubMed Web of Science ®Google Scholar
• Agren R, Bordel S, Mardinoglu A, et al. Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput Biol. 2012;8(5):e1002518. doi:10.1371/journal.pcbi.1002518.
   PubMed Web of Science ®Google Scholar
• Thiele I, Swainston N, Fleming RMT, et al. A community-driven global reconstruction of human metabolism. Nat Biotechnol. 2013;31(5):419–425. doi:10.1038/nbt.2595.
   PubMed Web of Science ®Google Scholar
• Folger O, Jerby L, Frezza C, et al. Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol. 2011;7(501):501. doi:10.1038/msb.2011.35.
   PubMed Web of Science ®Google Scholar
• Jerby L, Ruppin E. Predicting drug targets and biomarkers of cancer via genome-scale metabolic modeling. Clin Cancer Res. 2012;18(20):5572–5584. doi:10.1158/1078-0432.CCR-12-1856.
   PubMed Web of Science ®Google Scholar
• Kim TY, Kim HU, Lee SY. Metabolite-centric approaches for the discovery of antibacterials using genome-scale metabolic networks. Metab Eng. 2010;12(2):105–111. doi:10.1016/j.ymben.2009.05.004.
   PubMed Web of Science ®Google Scholar
• Dietmair S, Hodson MP, Quek L-E, et al. A multi-omics analysis of recombinant protein production in Hek293 cells. PloS One. 2012;7(8):e43394. doi:10.1371/journal.pone.0043394.
   PubMed Web of Science ®Google Scholar
• Lewis NE, Schramm G, Bordbar A, et al. Large-scale in silico modeling of metabolic interactions between cell types in the human brain. Nat Biotechnol. 2010;28(12):1279–1285. doi:10.1038/nbt.1665.
   PubMed Web of Science ®Google Scholar
• Quek L-E, Dietmair S, Hanscho M, et al. Reducing Recon 2 for steady-state flux analysis of HEK cell culture. J Biotechnol. 2014;184:172–178. doi:10.1016/j.jbiotec.2014.05.001.
   PubMed Web of Science ®Google Scholar
• Schellenberger J, Que R, Fleming RMT, et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat Protoc. 2011;6(9):1290–1307. doi:10.1038/nprot.2011.308.
   PubMed Web of Science ®Google Scholar
• Kim HU, Sohn SB, Lee SY. Metabolic network modeling and simulation for drug targeting and discovery. Biotechnol J. 2012;7(3):330–342. doi:10.1002/biot.201100407.
   PubMed Web of Science ®Google Scholar
• Kim HU, Kim SY, Jeong H, et al. Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol Syst Biol. 2014;7(1):460–460. doi:10.1038/msb.2010.115.
   Web of Science ®Google Scholar
• Nolan RP, Lee K. Dynamic model of CHO cell metabolism. Metab Eng. 2011;13(1):108–124. doi:10.1016/j.ymben.2010.09.003.
   PubMed Web of Science ®Google Scholar
• Valonen PK, Griffin JL, Lehtimäki KK, et al. High-resolution magic-angle-spinning 1H NMR spectroscopy reveals different responses in choline-containing metabolites upon gene therapy-induced programmed cell death in rat brain glioma. NMR Biomed. 2005;18(4):252–259. doi:10.1002/nbm.955.
   PubMed Web of Science ®Google Scholar
• Mansson S. Hyperpolarized nuclei for NMR imaging and spectroscopy [Ph.D. thesis]. Lund: Lund University; 2002.
   Google Scholar
• Stolyar S, Van Dien S, Hillesland KL, et al. Metabolic modeling of a mutualistic microbial community. Mol Syst Biol. 2007;3(92):92. doi:10.1038/msb4100131.
   PubMed Web of Science ®Google Scholar
• Yıldırım MA, Goh K-I, Cusick ME, et al. Drug—target network. Nat Biotechnol. 2007;25(10):1119–1126. doi:10.1038/nbt1276.
   PubMed Web of Science ®Google Scholar
• Stelzl U, Worm U, Lalowski M, et al. A human protein–protein interaction network: a resource for annotating the proteome. Cell. 2005;122(6):957–968. doi:10.1016/j.cell.2005.08.029.
   PubMed Web of Science ®Google Scholar
• Lee D-S, Park J, Kay KA, et al. The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci U S A. 2008;105(29):9880–9885. doi:10.1073/pnas.0802208105.
   PubMed Web of Science ®Google Scholar
• Benson N. Network-based discovery through systems biology network-based discovery through mechanistic systems biology. Implications for applications – SMEs and drug discovery : where the action is. Drug Discov Today Technol. 2015;15:41–48. doi:10.1016/j.ddtec.2015.07.003.
   PubMedGoogle Scholar
• Federowicz S, Kim D, Ebrahim A, et al. Determining the control circuitry of redox metabolism at the genome-scale. PLoS Genet. 2014;10(4):e1004264. doi:10.1371/journal.pgen.1004541.
   Google Scholar
• Wierling C, Kessler T, Ogilvie LA, et al. Network and systems biology: essential steps in virtualising drug discovery and development. Drug Discov Today Technol. 2015;15:33–40. doi:10.1016/j.ddtec.2015.07.002.
   PubMedGoogle Scholar
• Topfer N, Kleessen S, Nikoloski Z. Integration of metabolomics data into metabolic networks. Front Plant Sci. 2015;6(Feb):49.
   PubMed Web of Science ®Google Scholar
• Martínez VS, Quek L-E, Nielsen LK. Network thermodynamic curation of human and yeast genome-scale metabolic models. Biophys J. 2014;107(2):493–503. doi:10.1016/j.bpj.2014.10.055.
   PubMed Web of Science ®Google Scholar
• Aurich MK, Paglia G, Rolfsson Ó, et al. Prediction of intracellular metabolic states from extracellular metabolomic data. Metabolomics. 2015;11(3):603–619. doi:10.1007/s11306-014-0721-3.
   PubMed Web of Science ®Google Scholar
• Mo ML, Palsson BØ, Herrgård MJ. Connecting extracellular metabolomic measurements to intracellular flux states in yeast. BMC Syst Biol. 2009;3(1):37. doi:10.1186/1752-0509-3-43.
   PubMed Web of Science ®Google Scholar
• Adams JC, Keiser MJ, Basuino L, et al. A mapping of drug space from the viewpoint of small molecule metabolism. PLoS Comput Biol. 2009;5(8):e1000474. doi:10.1371/journal.pcbi.1000509.
   Google Scholar
• Kreyenschulte D, Paciok E, Regestein L, et al. Online monitoring of fermentation processes via non-invasive low-field NMR. Biotechnol Bioeng. 2015;112(9):1810–1821. doi:10.1002/bit.25599.
   PubMed Web of Science ®Google Scholar
• De Graaf A, Wittig R, Probst U, et al. Continuous-flow NMR bioreactor for in vivo studies of microbial cell suspensions with low biomass concentrations. J Magn Reson. 1992;98(3):654–659.
   Web of Science ®Google Scholar
• Wishart DS. Metabolomics for drug discovery, development and monitoring. Touch Briefing-Future Drug Discov. 2006;2006:1–3.
   Google Scholar
• Nicholson JK, Holmes E, Kinross JM, et al. Metabolic phenotyping in clinical and surgical environments. Nature. 2012;491(7424):384–392. doi:10.1038/nature11708.
   PubMed Web of Science ®Google Scholar
• Coen M, Holmes E, Lindon JC, et al. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol. 2008;21(1):9–27. doi:10.1021/tx700335d.
   PubMed Web of Science ®Google Scholar
• Holmes E, Loo RL, Stamler J, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature. 2008;453(7193):396–400. doi:10.1038/nature06882.
   PubMed Web of Science ®Google Scholar
• Holmes E, Wilson ID, Nicholson JK. Metabolic phenotyping in health and disease. Cell. 2008;134(5):714–717. doi:10.1016/j.cell.2008.08.026.
   PubMed Web of Science ®Google Scholar
• Smith LM, Maher AD, Want EJ, et al. Large-scale human metabolic phenotyping and molecular epidemiological studies via 1H NMR spectroscopy of urine: investigation of borate preservation. Anal Chem. 2009;81(12):4847–4856. doi:10.1021/ac9004875.
   PubMed Web of Science ®Google Scholar
• Jacobs A. An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs. Toxicol Lett. 2009;186:32–35. doi:10.1016/j.toxlet.2008.08.013.
   PubMed Web of Science ®Google Scholar
• Clayton AT, Lindon JC, Cloarec O, et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature. 2006;440(7087):1073–1077. doi:10.1038/nature04648.
   PubMed Web of Science ®Google Scholar
• Everett JR. Pharmacometabonomics in humans: a new tool for personalized medicine. Pharmacogenomics. 2015;16:737–754.
   PubMed Web of Science ®Google Scholar
• Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 2008;48:653–683. doi:10.1146/annurev.pharmtox.48.113006.094715.
   PubMed Web of Science ®Google Scholar
• Dhanasekaran AR, Pearson JL, Ganesan B, et al. Metabolome searcher: a high throughput tool for metabolite identification and metabolic pathway mapping directly from mass spectrometry and using genome restriction. BMC Bioinformatics. 2015;16(1):62. doi:10.1186/s12859-015-0462-y.
   PubMed Web of Science ®Google Scholar
• Cox DG, Oh J, Keasling A, et al. The utility of metabolomics in natural product and biomarker characterization. Biochim Biophys Acta. 2014;1840(12):3460–3474. doi:10.1016/j.bbagen.2014.08.007.
   PubMed Web of Science ®Google Scholar
• Fang M, Ivanisevic J, Johnson CH, et al. Thermal degradation of small molecules: a global metabolomic investigation. Anal Chem. 2015;87(21):10935–10941.
   Web of Science ®Google Scholar
• Aretz I, Meierhofer D. Advantages and pitfalls of mass spectrometry based metabolome profiling in systems biology. Int J Mol Sci. 2016 Apr 27;17(5):E632.
   PubMedGoogle Scholar
• Jacob RB, Andersen T, McDougal OM. Accessible high-throughput virtual screening molecular docking software for students and educators. PLoS Comput Biol. 2012;8(5):e1002499. doi:10.1371/journal.pcbi.1002499.
   PubMed Web of Science ®Google Scholar